drugset / Trial / NCT05897918
Tranexamic Acid in Treatment of Facial Erythema
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Our aim is to evaluate the efficacy of 10% topical tranexamic acid with microneedling in treatment of facial erythema
Timeline
- Start
- 2020-08-01
- Primary completion
- 2022-08-01
- Completion
- 2022-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 10 % | Topical |
| Subject | Tranexamic Acid | Small molecule | 500 mg | Topical |
Indications
No indication recorded.